SynopsisThe global Human Osteocalcin ELISA Kit market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Human Osteocalcin ELISA Kit is estimat.....
SynopsisBy type, the emergency medical products market is segmented into patient monitoring equipment, patient handling equipment, wound care products, infection control consumables, personal protection equipment, and life support and emergency resuscitation equipment.....
SynopsisThe global External Bone Fixation Plate market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of External Bone Fixation Plate in various end use industries. T.....
SynopsisTocotrienols Supplement is a dietary supplement that contains bioavailable tocotrienols from the extracts of pure rainforest annatto plants, using a solvent-free extraction method. This often overlooked form of vitamin E has been found to promote the support o.....
SynopsisMultiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptom.....
SynopsisVolumetric infusion pumps (VIP) are medical devices capable of delivering continuous and very specific amounts of fluids at very slow to very fast rates. Global Volumetric Infusion Pumps market is projected to reach US$ 937.6 million in 2029, increasing .....
SynopsisPoint of Care (POC) Devices are medical tools and tests that are designed to be used at or near the location where patient care is provided. These devices provide rapid and often immediate diagnostic results, enabling healthcare professionals to make timely de.....
SynopsisLeft Ventricular Assist Device is used to treat heart failure, as the bridge to transplant or destination therapy. The global Left Ventricular Assist Device Treatment market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 .....
SynopsisRanibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that is approved to treat the "wet" type of age-related macular degenerat.....
SynopsisThe global Cardiology Point-of-Care (POC) Diagnostics market was valued at US$ 134.6 million in 2023 and is anticipated to reach US$ 233.7 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030. The global pharmaceutical market i.....
